These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 24748223)

  • 21. The treatment of sickle cell anemia and Wilson's disease with zinc.
    Brewer GJ; Hill GM
    Prog Clin Biol Res; 1983; 127():97-113. PubMed ID: 6889406
    [No Abstract]   [Full Text] [Related]  

  • 22. Copper and Zinc Dysregulation in Alzheimer's Disease.
    Sensi SL; Granzotto A; Siotto M; Squitti R
    Trends Pharmacol Sci; 2018 Dec; 39(12):1049-1063. PubMed ID: 30352697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of zinc in the pathogenesis and treatment of central nervous system (CNS) diseases. Implications of zinc homeostasis for proper CNS function.
    Tyszka-Czochara M; Grzywacz A; Gdula-Argasińska J; Librowski T; Wiliński B; Opoka W
    Acta Pol Pharm; 2014; 71(3):369-77. PubMed ID: 25265815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Laser ablation inductively coupled plasma mass spectrometry imaging of metals in experimental and clinical Wilson's disease.
    Boaru SG; Merle U; Uerlings R; Zimmermann A; Flechtenmacher C; Willheim C; Eder E; Ferenci P; Stremmel W; Weiskirchen R
    J Cell Mol Med; 2015 Apr; 19(4):806-14. PubMed ID: 25704483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Symptomatic copper deficiency in three Wilson's disease patients treated with zinc sulphate.
    Dzieżyc K; Litwin T; Sobańska A; Członkowska A
    Neurol Neurochir Pol; 2014; 48(3):214-8. PubMed ID: 24981187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The link between copper and Wilson's disease.
    Purchase R
    Sci Prog; 2013; 96(Pt 3):213-23. PubMed ID: 24244969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Muscle copper, zinc, and manganese levels in Wilson's disease: studies with the use of neutron-activation analysis.
    Leu ML; Strickland GT; Beckner WM; Chen TS; Wang CC; Yeh SJ
    J Lab Clin Med; 1970 Sep; 76(3):432-8. PubMed ID: 5458332
    [No Abstract]   [Full Text] [Related]  

  • 28. The molecular basis of copper homeostasis copper-related disorders.
    Llanos RM; Mercer JF
    DNA Cell Biol; 2002 Apr; 21(4):259-70. PubMed ID: 12042066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disruption of zinc homeostasis and the pathogenesis of senile dementia.
    Kawahara M; Mizuno D; Koyama H; Konoha K; Ohkawara S; Sadakane Y
    Metallomics; 2014 Feb; 6(2):209-19. PubMed ID: 24247360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. On zinc deficiency.
    van den Hamer CJ; Cornelisse C
    Sci Total Environ; 1985 Mar; 42(1-2):83-9. PubMed ID: 4012291
    [No Abstract]   [Full Text] [Related]  

  • 31. Discovery of human zinc deficiency: its impact on human health and disease.
    Prasad AS
    Adv Nutr; 2013 Mar; 4(2):176-90. PubMed ID: 23493534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regional serotonin transporter availability and depression are correlated in Wilson's disease.
    Hesse S; Barthel H; Hermann W; Murai T; Kluge R; Wagner A; Sabri O; Eggers B
    J Neural Transm (Vienna); 2003 Aug; 110(8):923-33. PubMed ID: 12898347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Current views on the pathogenesis of Wilson's disease].
    Szeliga J
    Pediatr Pol; 1973 Mar; 48(3):381-4. PubMed ID: 4571542
    [No Abstract]   [Full Text] [Related]  

  • 34. Ultrastructural evaluation of activated forms of microglia in human brain in selected neurological diseases (SSPE, Wilson's disease and Alzheimer's disease).
    Lewandowska E; Wierzba-Bobrowicz T; Kosno-Kruszewska E; Lechowicz W; Schmidt-Sidor B; Szpak GM; Bertrand E; Pasennik E; Gwiazda E
    Folia Neuropathol; 2004; 42(2):81-91. PubMed ID: 15266782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New insights into the pathogenesis of copper toxicosis in Wilson's disease: evidence for copper incorporation and defective canalicular transport of caeruloplasmin.
    Chowrimootoo GF; Ahmed HA; Seymour CA
    Biochem J; 1996 May; 315 ( Pt 3)(Pt 3):851-5. PubMed ID: 8645167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of zinc and copper ions in the pathogenetic mechanisms of traumatic brain injury and Alzheimer's disease.
    Isaev NK; Stelmashook EV; Genrikhs EE
    Rev Neurosci; 2020 Apr; 31(3):233-243. PubMed ID: 31747384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of Wilson's disease with Zincteral].
    Kuczyńska-Zardzewiały A; Rodo M; Członkowska A
    Neurol Neurochir Pol; 1988; 22(3):211-5. PubMed ID: 3221958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tissue copper, zinc, and manganese levels in Wilson's disease: studies with the use of neutron activation analysis.
    Yeh SJ; Leu ML; Strickland GT
    J Lab Clin Med; 1971 Mar; 77(3):438-44. PubMed ID: 5553728
    [No Abstract]   [Full Text] [Related]  

  • 39. The spectrum of psychiatric symptoms in Wilson's disease: treatment and prognostic considerations.
    Zimbrean PC; Schilsky ML
    Am J Psychiatry; 2015 Nov; 172(11):1068-72. PubMed ID: 26575449
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of oral ZnSO4 on urine copper and blood trace elements in 60 patients with Wilson's disease].
    Yang RM
    Zhonghua Yi Xue Za Zhi; 1986 Apr; 66(4):211-3, 254. PubMed ID: 3094875
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.